Table 1.
Methods for CTCs isolation divided by the enrichement strategy.
Enrichment Strategy | Technology | Selection Criteria | Ref. |
---|---|---|---|
Immunomagnetic enrichment | |||
Immunomagnetic positive enrichment | CellSearch® | EpCam | (66) |
MagSweeper | EpCam | (95) | |
Magnetic Activated Cell Sorter (MACS) | EpCam | (96) | |
Strep-Tag | EpCam, EGFR, HER2 | (97) | |
Immuno-magnetosomes (IMS) | EpCam | (98) | |
AdnaTest | EpCam | (99) | |
Immunomagnetic negative enrichment | EasySep | CD45 | (100) |
RosetteSep | CD45 | (101) | |
Microfluidic positive capture | CTC-Chip | EpCam | (102) |
Isoflux | EpCam | (103) | |
Nanovelcro | EpCam | (104) | |
High-throughput Microsampling Unit (HTMSU) | EpCam | (105) | |
Verifast | EpCam | (106) | |
Size-based enrichment | |||
Microfluidics | Parasortix | Gap sizes from 10 μm down to 4.5 μm | (107) |
Microcavity Array (MCA) | 8-μm circular cavities | (108) | |
Density-based | OncoQuick | Density | (109) |
AccuCyte | Density | (110) | |
Membrane filtration | Isolation by Size of Tumor cells (ISET) | 8 μm pores | (111) |
Flexible micro spring array (FMSA) | 8 μm pores | (112) | |
ScreenCell | 6.5 µm pores | (113) | |
Fluid Assisted System Technology (FAST) | 8 μm pores | (114) | |
Dielectrophoresis | |||
Dielectric properties | ApoStream | Polarizability | (115) |
In vivo | |||
Therapeutic apheresis | Diagnostic leukapheresis | EpCam | (116) |
GILUPI CellCollector | EpCam | (117) |